4 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and ... inhibitors - Canagliflozin ... (Invokana) - Dapagliflozin ... (Steglatro) #diabetes ... #renal #SGLT2i
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... + T2DM; first renal ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin ... #inhibitors #EBM
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... SGLT2 inhibitors ... treatment of type II diabetes ... provide significant cardiovascular ... , #dapagliflozin
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
the Effects of Canagliflozin ... on Renal and Cardiovascular ... dipeptidyl peptidase 4 inhibitor ... receptor agonist; SGLT2i ... , SGLT2 inhibitor